{"id":"NCT01475643","sponsor":"Bausch & Lomb Incorporated","briefTitle":"Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.","officialTitle":"Safety and Efficacy of Topical Loteprednol Etabonate 0.5%, Versus Prednisolone Acetate 1%, for the Treatment of Intraocular Inflammation Following Surgery for Childhood Cataract","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06","primaryCompletion":"2017-06-02","completion":"2017-07","firstPosted":"2011-11-21","resultsPosted":"2019-06-11","lastUpdate":"2019-06-11"},"enrollment":107,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Cataract"],"interventions":[{"type":"DRUG","name":"Loteprednol etabonate","otherNames":["LE"]},{"type":"DRUG","name":"Prednisolones acetate","otherNames":["PA"]}],"arms":[{"label":"Loteprednol etabonate","type":"EXPERIMENTAL"},{"label":"Prednisolones acetate","type":"ACTIVE_COMPARATOR"}],"summary":"The objective of this study is to compare the efficacy and safety for the treatment of postoperative inflammation following ocular surgery for childhood cataract.","primaryOutcome":{"measure":"Anterior Chamber Inflammation","timeFrame":"Postoperative Day 29","effectByArm":[{"arm":"Loteprednol Etabonate","deltaMin":0.913,"sd":null},{"arm":"Prednisolones Acetate","deltaMin":0.783,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":54},"commonTop":["Eye Pain","Eyelid Odema","Nasopharyngitis","Discomfort","Ocular hyperemia"]}}